Acquisition - January 9, 2015
Companies Reach Commercialization Deal
Helsinn Group and Denmark’s Pharmacosmos A/S announced that they have reached an agreement for the exclusive U.S. commercialization rights to Monofer®, an innovative intravenous iron replacement therapy under development for the treatment of Iron Deficiency Anemia. Helsinn received the exclusive rights to commercialize Monofer® and any other iron isomaltoside 1000 products developed by Pharmacosmos in the […]
Uncategorized - January 9, 2015
Blood Stem Cells Create Veins
Medical researchers at Sahlgrenska Academy in Gothenburg, Sweden, have found a way to take stem cells directly from blood to generate new vessels. About 25 milliliters of blood were sufficient to generate a new vein. The new method accelerates the process and is far less painful than the past practice, which involved extracting stem cells from bone marrow. […]
Companies - January 8, 2015
Clinical Trial Site Gets Makeover
MediciGlobal’s revamped website provides detailed information on its recruitment, retention and rescue services for clinical trials. MediciGroup d/b/a MediciGlobalprovides clinical trial patient recruitment and retention solutions for the life sciences industry. Its L2FU division (Lost to Follow Up) focuses on locating missing patients to meet regulatory requirements for clinical trials. The website also integrates social […]
Agreement - January 8, 2015
Sobi, Exelixis Extend Agreement
Swedish Orphan Biovitrum AB (Sobi) has restructured and extended an agreement with Exelixis, Inc. to December 31, 2019. Sobi is responsible for the commercialization and distribution of Cometriq® (cabozantinib) for progressive, unresectable, locally advanced or metastatic medullary thyroid cancer (MTC) in the European Union (EU), Switzerland, Norway, Russia and Turkey. The collaboration originated in February […]
In a new job - January 8, 2015
Astra Names New Staff
AstraZeneca announced that Robert Iannone would be taking over its immuno-oncology drug development operations, a little more than a month after former senior vice president and head of immuno-oncology Rachel Humphrey left the company for undisclosed personal reasons at the end of November 2014. At about the same time, Peter Emtage, who was part of […]
Uncategorized - January 7, 2015
Stem Cells Reduce Heart Attack Effects
Transplanting mouse stem cells from fatty tissue to the same mouse can reduce damage from a heart attack, researchers at the University of Oslo discovered. During a study, stem cells were transplanted into the neck of the mice. After some time the researchers induced a heart attack in the mice in a controlled environment, subsequently testing heart function […]
